The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE Registry

• Published in: Pulmonary circulation Vol. 9; no. 2; pp. 1 - 9
• Main Authors: Billings, Catherine G., Lewis, Robert, Hurdman, Judith A., Condliffe, Robin, Elliot, Charlie A., Thompson, A.A. Roger, Smith, Ian A., Austin, Matthew, Armstrong, Iain J., Hamilton, Neil, Charalampopoulos, Athanasios, Sabroe, Ian, Swift, Andrew J., Rothman, Alexander M., Wild, Jim M., Lawrie, Allan, Waterhouse, Judith C., Kiely, David G.
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 01-04-2019; John Wiley & Sons, Inc; Wiley
• Subjects: disease severity; exercise testing; prognosis; Pulmonary hypertension; disease severity; prognosis; exercise testing
• ISSN: 2045-8940; 2045-8932; 2045-8940
• DOI: 10.1177/2045894019848649

Pulmonary hypertension (PH) is classified into five groups based on disease etiology but there is only limited information on the prognostic value of exercise testing in non-group 1 PH. In group 1 PH, the incremental shuttle walking test (ISWT) distance has been shown to correlate with pulmonary hemodynamics and predict survival without a ceiling effect. This study assessed the ISWT in non-group 1 PH. Data were retrieved from the ASPIRE Registry (Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre) for consecutive patients diagnosed with PH. Patients were required to have been systematically assessed as group 2–5 PH and to have a baseline ISWT within three months of cardiac catheterization. Patients were stratified according to incremental shuttle walk test distance (ISWD) and ISWT distance percent predicted (ISWD%pred). A total of 479 patients with non-group 1 PH were identified. ISWD and ISWD%pred correlated significantly with symptoms and hemodynamic severity. ISWD and ISWD%pred predicted survival with no ceiling effect. The test was prognostic in groups 2, 3, and 4. ISWD and ISWD%pred and change in ISWD and ISWD%pred at one year were all significant predictors of outcome. In patients with non-group 1 PH the ISWT is a simple non-invasive test that is easy to perform, is predictive of survival at baseline and follow-up, reflects change, and can be used in the assessment of PH of any etiology.